Patrick G Enright - Net Worth and Insider Trading
Patrick G Enright Net Worth
The estimated net worth of Patrick G Enright is at least $584 Million dollars as of 2024-07-05. Patrick G Enright is the Director of Aimmune Therapeutics Inc and owns about 6,183,695 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $213 Million. Patrick G Enright is the Director of Corcept Therapeutics Inc and owns about 6,108,328 shares of Corcept Therapeutics Inc (CORT) stock worth over $186 Million. Patrick G Enright is also the Director, 10% Owner of Vera Therapeutics Inc and owns about 5,144,212 shares of Vera Therapeutics Inc (VERA) stock worth over $179 Million. Besides these, Patrick G Enright also holds Esperion Therapeutics Inc (ESPR) , Jazz Pharmaceuticals PLC (JAZZ) , Aptinyx Inc (APTX) . Details can be seen in Patrick G Enright's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Patrick G Enright has not made any transactions after 2023-08-14 and currently still holds the listed stock(s).
Transaction Summary of Patrick G Enright
Patrick G Enright Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick G Enright owns 21 companies in total, including Eargo Inc (EAR) , Aimmune Therapeutics Inc (AIMT) , and Aptinyx Inc (APTX) among others .
Click here to see the complete history of Patrick G Enright’s form 4 insider trades.
Insider Ownership Summary of Patrick G Enright
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EAR | Eargo Inc | 2020-10-15 | 10 percent owner |
AIMT | Aimmune Therapeutics Inc | 2020-10-10 | director |
APTX | Aptinyx Inc | 2020-01-10 | director & 10 percent owner |
2019-11-25 | 10 percent owner | ||
2023-08-14 | director & 10 percent owner | ||
2020-07-23 | 10 percent owner | ||
2019-11-08 | 10 percent owner | ||
2020-06-11 | 10 percent owner | ||
2019-11-22 | 10 percent owner | ||
2019-11-07 | 10 percent owner | ||
2018-10-30 | 10 percent owner | ||
2018-06-27 | 10 percent owner | ||
2015-05-06 | 10 percent owner | ||
2017-07-19 | 10 percent owner | ||
2017-03-16 | director & 10 percent owner | ||
2015-03-19 | director | ||
2007-06-22 | director | ||
2021-07-19 | 10 percent owner | ||
2021-05-06 | 10 percent owner | ||
2023-02-06 | director & 10 percent owner | ||
2023-11-02 | 10 percent owner |
Patrick G Enright Latest Holdings Summary
Patrick G Enright currently owns a total of 6 stocks. Among these stocks, Patrick G Enright owns 6,183,695 shares of Aimmune Therapeutics Inc (AIMT) as of March 18, 2020, with a value of $213 Million and a weighting of 36.53%. Patrick G Enright owns 6,108,328 shares of Corcept Therapeutics Inc (CORT) as of March 16, 2017, with a value of $186 Million and a weighting of 31.91%. Patrick G Enright also owns 5,144,212 shares of Vera Therapeutics Inc (VERA) as of February 6, 2023, with a value of $179 Million and a weighting of 30.75%. The other 3 stocks Esperion Therapeutics Inc (ESPR) , Jazz Pharmaceuticals PLC (JAZZ) , Aptinyx Inc (APTX) have a combined weighting of 0.81% among all his current holdings.
Latest Holdings of Patrick G Enright
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AIMT | Aimmune Therapeutics Inc | 2020-03-18 | 6,183,695 | 34.49 | 213,275,641 |
CORT | Corcept Therapeutics Inc | 2017-03-16 | 6,108,328 | 30.50 | 186,304,004 |
VERA | Vera Therapeutics Inc | 2023-02-06 | 5,144,212 | 34.89 | 179,481,557 |
ESPR | Esperion Therapeutics Inc | 2015-03-19 | 934,396 | 2.36 | 2,205,175 |
JAZZ | Jazz Pharmaceuticals PLC | 2023-08-14 | 20,946 | 103.53 | 2,168,539 |
APTX | Aptinyx Inc | 2020-01-10 | 3,451,746 | 0.10 | 331,368 |
Holding Weightings of Patrick G Enright
Patrick G Enright Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick G Enright has made a total of 1 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 125,000 shares on March 18, 2020, which cost Patrick G Enright around $1 Million.
According to the SEC Form 4 filings, Patrick G Enright has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 269,955 shares on March 16, 2017, which brought Patrick G Enright around $3 Million.
According to the SEC Form 4 filings, Patrick G Enright has made a total of 2 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vera Therapeutics Inc is the acquisition of 1,714,285 shares on February 6, 2023, which cost Patrick G Enright around $12 Million.
More details on Patrick G Enright's insider transactions can be found in the Insider Trading History of Patrick G Enright table.Insider Trading History of Patrick G Enright
- 1
Patrick G Enright Trading Performance
GuruFocus tracks the stock performance after each of Patrick G Enright's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick G Enright is 14.91%. GuruFocus also compares Patrick G Enright's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick G Enright within 3 months outperforms 9 times out of 13 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patrick G Enright's insider trading performs compared to the benchmark.
Performance of Patrick G Enright
Patrick G Enright Ownership Network
Ownership Network List of Patrick G Enright
Ownership Network Relation of Patrick G Enright
Patrick G Enright Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Patrick G Enright is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, Patrick G Enright made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Patrick G Enright Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick G Enright. You might contact Patrick G Enright via mailing address: Co Longitude Capital Partners Llc, 800 El Camino Real, Suite 220, Menlo Park Ca 94025.